Dallas-based Kai Medical Lab Ready to Meet Continued Demand for COVID-19 Vaccines Through Drive Up Programs, Booster Clinics, and School Vaccination Programs
VANCOUVER, BC / ACCESSWIRE / October 25, 2021 / EMPOWER CLINICS INC. (CSE: CBDT) (Frankfurt: 8EC) (OTCQB: EPWCF) (“Empower“or the”Society“) an integrated healthcare business – serving patients through medical centers, telemedicine platforms, a medical device business and a highly complex medical diagnostic laboratory processing thousands of samples COVID-19 – is pleased to announce that Kai Medical Laboratory (“Kai Lab”) has received approval to be a COVID-19 pandemic supplier capable of delivering COVID-19 vaccines in the United States
In mid-October, the Texas Department of State Health Services (DSHS) and the United States Department of Health and Human Services (HHS) received and successfully approved Kai Lab’s request. Kai Lab can immediately begin placing orders for Pfizer-BioNTech and Johnson & Johnson COVID-19 vaccines. As part of the application process, Kai Lab needed a purchase of freezers (-80 degrees Celsius) and data history of DSHS-compliant vaccine temperature data loggers, as well as proof trained and certified staff capable of cataloging and administering vaccinations. Through government COVID-19 vaccination portals, businesses, schools, and other groups can connect directly with Kai Labs to coordinate vaccination clinics.
“I am extremely proud of the Kai team for completing this complex approval process,” said Steven McAuley, President and CEO of Empower. “Kai Lab is a state-of-the-art facility and, thanks to its recent expansion, its facilities and staff have been able to qualify to meet the continued demand for COVID-19 vaccines. The United States has made history with the speed of its vaccination program, and the Empower team is eager to provide additional access through convenient vaccination clinics, starting with the Texas market. “
Yoshi Tyler, President of Kai Medical Laboratory, added: “I am delighted to announce that Kai Medical Laboratory will now be a vaccine supplier for Pfizer-BioNTech and Janssen. The addition of vaccines to our current suite of services will provide our customers with a broader and more comprehensive suite of services. Aided by our recent expansion, we are achieving our goals of providing innovative testing and healthcare solutions to millions of people. “
Since the start of the pandemic, the US government has invested more than $ 10 billion in the production, manufacture and distribution of COVID-19 vaccines. The Company expects to earn US $ 40 per vaccine administered through government vaccine delivery programs. Kai Lab’s has placed its initial batch orders which include 1,200 vaccines per batch, with the initial batch expected to arrive within two weeks.
Vaccinations have been a critical tool for the safe reopening of businesses, schools, and other activities in 2021. Yet despite the majority number of vaccinations in the United States, only 67% of all Americans are fully vaccinated and only 77% have at least one dose. The numbers have risen in recent weeks as more employers and jurisdictions implement some variation in mandatory vaccinations. Since August, demand has also increased with booster shots made available to the elderly, those at high risk and those with weakened immune systems. Early vaccinations are expected to increase dramatically as the FDA meets in the coming weeks to review Pfizer and BioNTech’s request to allow emergency use of their COVID-19 vaccine for children aged five. at eleven years old. The move would vaccinate more than 28 million additional people in the United States, according to the New York Times.
ABOUT KAI MEDICAL LABORATORY:
The Kai Medical Laboratory is a highly complex laboratory accredited by Clinical Laboratory Improvement Amendments (CLIA) and Commission on Office Laboratory Accreditation (COLA). Our team is made up of experienced scientists, healthcare professionals and pharmacists. We provide reliable testing solutions to hospitals, medical clinics, pharmacies and employer groups. The Kai Medical Laboratory is focused on delivering opportunities that change our current healthcare system by improving the quality of life for employees and improving business outcomes for client companies. We offer diverse services across the country to meet the current demands of today’s healthcare needs.
Empower is an integrated healthcare company providing physical and mental well-being to patients through its clinics, with digital and telemedicine care, a medical device company and world-class medical diagnostic laboratories. Backed by an experienced management team, Empower is aggressively expanding its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously delivering long-term value for our shareholders.
ON BEHALF OF THE BOARD OF DIRECTORS:
Chief Executive Officer
Steven McAuley CEO
Business development and communication
DISCLAIMER FOR FORWARD-LOOKING STATEMENTS
This press release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward-looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as of the date of this press release. Forward-looking statements can often be identified by words such as “plans”, “continues”, “expects”, “plans”, “intends”, “believes”, “plans”, “estimates”, “Could”, “”, “potential”, “proposed” and other similar words, or information indicating that certain events or conditions “could” or “occur”. The forward-looking statements contained in this press release include, without limitation, statements regarding: the expected benefits to the Company and its shareholders as a result of the acquisition of Kai Medical Laboratory; the terms of the transaction; the expected number of clinics and patients after closure; the potential future success of Kai Medical Laboratory, the Sun Valley franchise model; the launch of new health centers and their appearance; that the Society can provide health care to millions of Canadians; that new healthcare services can be added and that the Company will be positioned to be a market-leading service provider for complex patient needs in 2020 and beyond. These statements are only projections, are based on assumptions currently known to management, and are subject to risks and uncertainties which may cause actual results, performance or developments to differ materially from those contained in forward-looking statements, including: that the Company will be able to successfully run COVID-19 vaccination programs through drive, recall, or school programs; that the Company’s products may not perform as expected; that the Company may not be able to expand COVID-19 testing; that legislative changes may have an adverse effect on the activities and product development of the Company; that the Company may not be able to obtain adequate financing to pursue its business plan; as general business, economic, competitive, political and social uncertainties; and other factors beyond the control of the Company. No assurance can be given that any of the events anticipated by forward-looking statements will occur or, if they occur, what benefits the Company will derive from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this press release, which are qualified in their entirety by these cautionary statements. The Company has no obligation and expressly disclaims any intention or obligation to update or revise any forward-looking statements contained in this press release, whether as a result of new information, future events or otherwise, except as expressly required. by applicable laws.
THE SOURCE: Empower Clinics Inc.
See the source version on accesswire.com: